Shanghai Rendu Biotechnology Co (688193.SS) Stock Price

Shanghai Rendu Biotechnology Co Price

CLOSED
51.50
​
Market closed

Over the last 7 years Shanghai Rendu Biotechnology Co grew revenue by 12.9% annually, reaching 161.94 M CNY. Earnings per share have grown at 18.0% per year over the last 6 years. For Shanghai Rendu Biotechnology Co, the net margin of 6.2% is down versus 22.1% a few years ago. At today's price the dividend yield works out to roughly 0.49%. The payout ratio is around 99% of earnings. The dividend has grown at 41.4% per year over the past 2 years.

Shanghai Rendu Biotechnology Co stock price

Access this data via the Eulerpool API

Shanghai Rendu Biotechnology Co business model & stock analysis

Shanghai Rendu Biotechnology Co., Ltd. develops molecular diagnostic tests. The company is headquartered in Shanghai, Shanghai and currently employs 528 full-time employees. The company went IPO on 2022-03-30. The firm utilizes ribonucleic acid (RNA) isothermal amplification technology to provides multiple series of diagnostic reagents, including respiration series, reproduction series, enterovirus series, blood-borne diseases series and other diagnostic reagents. The firm also designs and manufactures medical instruments. The firm mainly sells its products within domestic market.

Frequently asked questions about Shanghai Rendu Biotechnology Co

Converted at the current exchange rate, the Shanghai Rendu Biotechnology Co share trades at 6.86 EUR (51.50 CNY).

The revenue cannot currently be calculated for Shanghai Rendu Biotechnology Co.

The profit cannot currently be calculated for Shanghai Rendu Biotechnology Co.

The P/E ratio cannot be calculated for Shanghai Rendu Biotechnology Co at the moment.

The P/S cannot be calculated for Shanghai Rendu Biotechnology Co currently.

The Eulerpool Quality Score for Shanghai Rendu Biotechnology Co is 1/10.

The ISIN of Shanghai Rendu Biotechnology Co is CNE1000059K5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Shanghai Rendu Biotechnology Co is 688193.SS. The ticker symbol is used to trade Shanghai Rendu Biotechnology Co shares on the stock exchange.

Fair ValueTerminal
49.96 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
306,709.41 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website rdbio.com
Country
Currency
CNY
Initial public offering
Mar 30, 2022
ISIN
CNE1000059K5
Market capitalization
2.06 B CNYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
2.26
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1.10 %
Dividend
Dividend yield
0.49 %
Payout Ratio
99.13 %
Dividend growth Ø5Y
—
Dividend payments per year
2
Dividend paid since
3 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Oct 10, 2026, 6:13 PM

Shanghai Rendu Biotechnology Co Peer Group

Shanghai Rendu Biotechnology Co FIGI

688193:CH · BBG011J503P0688193:CG · BBG011J505C9